Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Ebinger
Timothy D Henry

Showing results (261-270 of 605) with videos related to

Pageof 61
Sort By:
American Heart Journal|May 15, 2018
Resource utilization and outcome among patients with selective versus nonselective troponin testingAlex R Campbell, Alexander J Rodriguez, David M Larson, et al.
Shock (Augusta, Ga.)|May 14, 2021
Laboratory Markers of Acidosis and Mortality in Cardiogenic Shock: Developing a Definition of Hemometabolic ShockJacob C Jentzer, Kianoush B Kashani, Brandon M Wiley, et al.
Circulation. Cardiovascular Interventions|January 31, 2024
Reperfusion in Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock and Prolonged Interhospital Transport TimesSean van Diepen, Yinggan Zheng, Janek M Senaratne, et al.
Journal of Cardiovascular Translational Research|December 8, 2010
Long-term follow-up of patients undergoing postconditioning during ST-elevation myocardial infarctionSantiago Garcia, Timothy D Henry, Yale L Wang, et al.
Circulation|November 9, 2011
Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increaseDuane S Pinto, Paul D Frederick, Anjan K Chakrabarti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2012
Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trialRichard J Powell, William A Marston, Scott A Berceli, et al.
American Heart Journal Plus : Cardiology Research and Practice|August 7, 2024
Evaluation of coronary microvascular dysfunction using magnetocardiography: A new application to an old technologyNamrita Ashokprabhu, Khaled Ziada, Edouard Daher, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 9, 2022
Increasing myocardial edema is associated with greater microvascular obstruction in ST-segment elevation myocardial infarctionNicole L Bonfig, Chase R Soukup, Ananya A Shah, et al.
JAMA|January 1, 2008
"False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarctionDavid M Larson, Katie M Menssen, Scott W Sharkey, et al.
Circulation Research|August 22, 2014
Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathyTimothy D Henry, Jay H Traverse, Baron L Hammon, et al.
Pageof 61

Showing results (261-270 of 605) with videos related to

Sort By:
Pageof 61
American Heart Journal|May 15, 2018
Resource utilization and outcome among patients with selective versus nonselective troponin testingAlex R Campbell, Alexander J Rodriguez, David M Larson, et al.
Shock (Augusta, Ga.)|May 14, 2021
Laboratory Markers of Acidosis and Mortality in Cardiogenic Shock: Developing a Definition of Hemometabolic ShockJacob C Jentzer, Kianoush B Kashani, Brandon M Wiley, et al.
Circulation. Cardiovascular Interventions|January 31, 2024
Reperfusion in Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock and Prolonged Interhospital Transport TimesSean van Diepen, Yinggan Zheng, Janek M Senaratne, et al.
Journal of Cardiovascular Translational Research|December 8, 2010
Long-term follow-up of patients undergoing postconditioning during ST-elevation myocardial infarctionSantiago Garcia, Timothy D Henry, Yale L Wang, et al.
Circulation|November 9, 2011
Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increaseDuane S Pinto, Paul D Frederick, Anjan K Chakrabarti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2012
Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trialRichard J Powell, William A Marston, Scott A Berceli, et al.
American Heart Journal Plus : Cardiology Research and Practice|August 7, 2024
Evaluation of coronary microvascular dysfunction using magnetocardiography: A new application to an old technologyNamrita Ashokprabhu, Khaled Ziada, Edouard Daher, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 9, 2022
Increasing myocardial edema is associated with greater microvascular obstruction in ST-segment elevation myocardial infarctionNicole L Bonfig, Chase R Soukup, Ananya A Shah, et al.
JAMA|January 1, 2008
"False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarctionDavid M Larson, Katie M Menssen, Scott W Sharkey, et al.
Circulation Research|August 22, 2014
Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathyTimothy D Henry, Jay H Traverse, Baron L Hammon, et al.
Pageof 61